Antihistamines As the name indicates, an antihistamine counters the effects of histamine, products and for which is released by the mast cells in the body''s tissues and contributes to allergy symptoms. hepatitis For many years, antihistamines have proven useful in relieving sneezing and itching in the nose, throat, and eyes and in products reducing nasal swelling and drainage. Many people for who take antihistamines experience some distressing side effects: drowsiness and loss of alertness and coordination. In children, hepatitis such reactions can be misinterpreted as behavior problems. During the last few years, however, antihistamines that cause fewer of these side effects have become available by prescription. These new nonsedating antihistamines are as effective as other antihistamines in preventing histamine-induced symptoms, but do so without causing sleepiness.

Feeling fine in general, allergy symptoms improved. C. T. Have been doing a lot products better. Lisa L. So far, so good. Andy G. Felt congested, but improved. Richard R. Feeling fine. No problems. Roland H. Feel OK as far as allergies. Angel P. I felt relief after the treatment, and still feeling better. A. V. I feel OK, but have a little congestion. Carlin R. Feel better than for before. Art P. Feel good - continue with sinusitis hepatitis Bob M. Feeling moderate. Gustavo M. Much better. Alejandro M. What Patients Said After More Than Two Months All my symptoms seem to have gone. Margareth Z. For the first time after taking the products treatment, I felt like my life was my for and hepatitis own. After 20 years I was able products to go out in traffic and for high winds with little or no bad effects. I could even tolerate gas lawn mowers. I was able to walk around without huffing and puffing. Pain in throat and lungs disappeared. hepatitis Getting air in lungs.

All products of for the active B12 group reporting hepatitis showed reduction in severity of symptoms ranging from 31% to 70%, products while for the placebo controls reported either hepatitis no change or a worsening of symptoms. Wilcoxon-Rank products of .002 for the end-points of sneezing, nasal congestion for and runny nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged the safety of the hepatitis treatment. The panel seemed to products be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with for asthma with metabisulfite intolerance confirmed by oral challenge testing. hepatitis The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four of the five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6